Branched polyethylenimine (PEI) chains with an average molecular mass of 2 kDa (PEI2) have been covalently attached to gold nanoparticles (GNPs), and the potency of the resulting PEI2-GNPs conjugates as vectors for the delivery of plasmid DNA into monkey kidney (COS-7) cells in the presence of serum in vitro has been systematically investigated. The transfection efficiencies vary as a function of the PEI͞gold molar ratio in the conjugates, with the best one (PEI2-GNPII) being 12 times more potent than the unmodified polycation. This potency can be further doubled by adding amphiphilic N-dodecyl-PEI2 during complex formation with DNA. The resulting ternary complexes are at least 1 order of magnitude more efficient than the 25-kDa PEI, one of the premier polycationic gene-delivery vectors. Importantly, although unmodified PEI2 transfects just 4% of the cells, PEI2-GNPII transfects 25%, and the PEI2-GNPII͞dodecyl-PEI2 ternary complex transfects 50% of the cells. The intracellular trafficking of the DNA complexes of these vectors, monitored by transmission electron microscopy, has detected the complexes in the nucleus <1 h after transfection.G ene therapy holds great promise for treating diseases ranging from inherited disorders to acquired conditions and cancer (1-4). The most common vectors (carriers) in current clinical trials are recombinant viruses, wherein the gene of interest is covalently inserted into the viral genome. Unfortunately, such severe side reactions encountered in patients as immune response and insertional mutagenesis leading to death, carcinogenesis, or germ-cell-line alterations pose serious concerns about the clinical application of viral vectors (5-7) and have prompted development of nonviral delivery systems (8-10). Unlike viral vectors, nonviral ones rely on the formation of noncovalent assemblies between DNA (a polyanion) and cationic polymers or liposomes. Vectors based on cationic polymers (polycations) are particularly attractive because of their synthetic maneuverability, allowing incorporation of multiple functional elements within the same molecule without compromising DNA-binding ability (11)(12)(13). And yet, available polycations are handicapped by their low potencies (14, 15), prompting the search for new ones with better transfection efficiencies (16)(17)(18)(19)(20). It is likely that major improvements may be brought about by elucidating the mechanism of gene delivery by those vectors already relatively competent, followed by their targeted chemical derivatization to overcome extra-and͞or intracellular barriers to nonviral gene delivery (10). For these reasons, polyethylenimine (PEI), a synthetic ''proton-sponge'' polycation (21-24) introduced for transfection a few years ago, is an ideal candidate for such a quest.The transfection efficiency and toxicity of PEI correlate strongly with its molecular mass. For example, PEI2 is some 2 orders of magnitude less efficient than its 25-kDa counterpart (PEI25) at the same concentration, presumably because of its inability to condense...